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The 57-residue small hydrophilic endoplasmic reticulum-
associated protein (SHERP) shows highly specific, stage-
regulated expression in the non-replicative vector-transmit-
ted stages of the kinetoplastid parasite, Leishmania major,
the causative agent of human cutaneous leishmaniasis. Pre-
vious studies have demonstrated that SHERP localizes as a
peripheral membrane protein on the cytosolic face of the
endoplasmic reticulum and on outer mitochondrial mem-
branes, whereas its high copy number suggests a critical
function in vivo. However, the absence of defined domains
or identifiable orthologues, together with lack of a clear
phenotype in transgenic parasites lacking SHERP, has lim-
ited functional understanding of this protein. Here, we use a
combination of biophysical and biochemical methods to
demonstrate that SHERP can be induced to adopt a globular
fold in the presence of anionic lipids or SDS. Cross-linking
and binding studies suggest that SHERP has the potential to
form a complex with the vacuolar type H-ATPase. Taken
together, these results suggest that SHERP may function in
modulating cellular processes related to membrane organi-
zation and/or acidification during vector transmission of
infective Leishmania.
Leishmaniasis, caused by the digenetic kinetoplastid para-
site Leishmania, is one of the world’s neglected diseases. Ac-
cording to the World Health Organization, an estimated 12
million people are currently infected, with up to 350 million
people at risk in 88 countries (1). Transmitted by blood-feed-
ing female sand flies, more than 20 species of Leishmania are
pathogenic in humans. Infection results in a range of clinical
conditions, with the visceral form of leishmaniasis usually
fatal if untreated (reviewed in Ref. 2). There are no licensed
vaccines for protection against infection, and postexposure
therapies are often ineffective, with unacceptable side ef-
fects. Co-infection with Leishmania and HIV presents an
additional complication, with parasite infection known to
accelerate the onset of AIDS (reviewed in Ref. 3). Clearly,
an improved understanding of the molecular mechanisms
leading to pathogenesis in humans is of key importance in
developing new therapeutic options for tackling these de-
bilitating diseases.
Leishmania cycles between extracellular life in the alimen-
tary tract of its sand fly vector and intracellular maintenance
within the acidic phagolysosomes of mammalian host macro-
phages. Following uptake during sand fly blood-feeding, di-
viding parasites reach a stationary growth phase prior to dif-
ferentiation, with the end point of that process being the
production of highly motile metacyclic organisms that are
preadapted for survival following inoculation into the host (4,
5). This differentiation is characterized by modifications to
the parasite surface glycocalyx, principally to the major
lipid-anchored glycoconjugate, lipophosphoglycan, that
confer complement resistance (6–9). At the same time,
other cellular processes, such as translation, are
down-regulated.
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In contrast, the 6.2-kDa small hydrophilic endoplasmic re-
ticulum-associated protein (SHERP)7 is exclusively expressed
in metacyclic parasites, the only highly expressed Leishmania
protein identified to date that is specific to these insect stage
organisms (10). SHERP is hydrophilic with an acidic pI and
shares no sequence identity with any other known protein, in
common with up to 40% of the proteins encoded by the Leish-
mania genomes (11, 12). Although SHERP has an unusual
dual localization at the cytosolic face of the ER and the mito-
chondrial outer membrane, in vivo cross-linking and fraction-
ation experiments have shown that it is a peripheral mem-
brane protein of as yet unknown function (10). Its unusually
high level of stage-specific expression (estimated at 100,000
molecules/cell), localization, and partial biochemical charac-
terization suggest that SHERP may have a vital function in
metacyclic parasites during transmission to the mammalian
host.
To gain an improved insight into the functional properties
of SHERP, we have used a combined biophysical and bio-
chemical approach to characterize the structure and interac-
tions of this protein both in vitro and in vivo. Using synchro-
tron radiation circular dichroism (SRCD) and NMR
spectroscopic methods, we show that SHERP adopts a globu-
lar fold when bound to either anionic phospholipids or SDS
detergent. Cross-linking and binding studies suggest that
SHERP can form a complex with a vacuolar type H-ATPase
(V-ATPase). From these data, we postulate that an anionic
environment or surface is a key molecular recognition tem-
plate for SHERP and may facilitate its ability to form a com-
plex with V-ATPase. Furthermore, formation of a membrane-
localized SHERPV-ATPase complex could in turn modulate
acidification processes that may prove important for the dif-
ferentiation of Leishmania within its sand fly vector.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Reagents—Escherichia coli strains
XL1-Blue and BL21(DE3) were obtained from Stratagene (La
Jolla, CA). Thermus thermophilus strain AH8 was a gift from
Professor Ken Yokoyama (Tokyo Institute of Technology,
Yokohama, Japan). Unless otherwise noted, chemicals were
purchased from Sigma-Aldrich. Oligonucleotides were syn-
thesized by Sigma-Genosys. Other suppliers were as follows:
Deep Vent DNA polymerase and T4 DNA ligase, New Eng-
land Biolabs (Hitchin, UK); restriction enzymes, Roche Ap-
plied Science and New England Biolabs; M199 medium, fetal
calf serum, and DNA molecular weight markers, Invitrogen;
isopropyl -D-thiogalactoside, Genesys (London, UK); Taq
PCR Ready-To-Go beads, protein molecular weight stand-
ards, and Coomassie Brilliant Blue R250, Amersham Biosci-
ences; reagents for production of Luria-Bertani (LB) medium,
Merck; Spectra 9-CN medium, Spectra Gases Ltd. (Cam-
bridge, UK); Centricon protein concentration devices, Milli-
pore (Watford, UK); UV-activated cross-linking reagent sulfo-
N-hydroxysuccinimidyl-2-(6-[biotinamido]-2-(p-
azidobenzamido)-hexanoamido) ethyl-1,3-dithioproprionate
(sulfo-SBED), ImmunoPure immobilized monomeric avi-
din, and Ultralink immobilized streptavidin, Pierce. Syn-
thetic phospholipids were purchased from Avanti Polar
Lipids (Alabaster, AL) as lyophilized solids, and Triton
X-100 and n-dodecyl--D-maltopyranoside were from
Anatrace, Inc. (Maumee, OH).
Cloning, Expression, and Purification of Recombinant
L. major SHERP—Plasmid DA-PET15/3 (10), which contains
the L. majorORF of SHERP1, was used as template in PCR
amplification with primers LmN_F (5-CCCCCCCCATGGT-
TCATCATCATCATCATCATTCTAGAGCTAGTTCGTA-
CACAATGGACCAGGAGACAAG-3) and LmN_R
(5-GGGAAAGGATCCTTACGAGCCACCGC-3). The
resulting PCR product contains NcoI and BamHI restriction
sites for cloning into the isopropyl -D-thiogalactoside-induc-
ible expression vector pET-28a(). The resulting construct,
pTLmCSHERP, was transformed into heat shock-competent
E. coli XL1-Blue cells and selected on L-agar containing 30
g/ml kanamycin. Plasmids were purified from single colo-
nies using the QIAprep spin minikit and subsequently
screened for the presence of the SHERP insert by PCR ampli-
fication screening using Taq Ready-To-Go PCR beads with
the T7 promoter and LmN_R primers. The DNA sequence of
the SHERP insert in PCR-positive plasmids was subsequently
confirmed by the Advanced Biotechnology Centre (Imperial
College London).
Plasmid pTLmCSHERP was next transformed into E. coli
strain BL21(DE3), and expression trials indicated that re-
combinant SHERP could be overproduced as a soluble pro-
tein. An optimized purification protocol was developed,
which was initiated by inoculating LB medium containing 30
g/ml kanamycin with a 1:100 dilution of an overnight cul-
ture of E. coli BL21(DE3)(pTLmCSHERP). Cells were grown
at 37 °C with shaking to A600 of 0.4–0.8. Isopropyl -D-thio-
galactoside was added to a final concentration of 1 mM, and
the cells were left at 37 °C for a further 4 h prior to harvesting
by centrifugation at 10,000 g and 4 °C for 25 min. Superna-
tants were discarded, and the cell pellets stored at20 °C un-
til required. Frozen cells were thawed at room temperature
and resuspended using 1.5% of the original culture volume in
a buffer containing 50 mM K2HPO4/KH2PO4, 300 mM NaCl, 5
mM imidazole, and 0.5 mM PMSF, pH 7.0. Lysozyme was then
added to produce a final concentration of 0.75 mg/ml, and the
cells were incubated at room temperature for 25 min prior to
lysis by sonication with three 30-s bursts, with 30-s intervals
on ice using an XL 2020 sonicator (Labcaire Systems Ltd.,
Avon, UK) at 60% intensity. Insoluble materials were pelleted
by centrifugation at 15,000 g and 4 °C for 25 min. The su-
pernatant was decanted and passed through a 0.45-m filter
(Millipore, Watford, UK) and then applied to prepared
TALON resin (BD Biosciences) in a Bio-Rad disposable plas-
tic column, and the flow-through was retained. SHERP was
eluted using 50 mM K2HPO4/KH2PO4, 300 mM NaCl, and 300
mM imidazole, pH 7.0. Elution fractions were analyzed by
7 The abbreviations used are: SHERP, small hydrophilic endoplasmic reticu-
lum-associated protein; SRCD, synchrotron radiation circular dichroism;
V-ATPase, vacuolar type H-ATPase; DOPC, 1,2-dioleoyl-sn-glycero-3-
phosphocholine; DOPE, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine;
DOPG, 1,2-dioleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)]; SBED, N-hy-
droxysuccinimidyl-2-(6-[biotinamido]-2-(p-azidobenzamido)-hexano-
amido) ethyl-1,3-dithioproprionate; ER, endoplasmic reticulum.
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SDS-PAGE, and SHERP fractions were pooled prior to con-
centration using a Centri-Prep YM-3 centrifugal filter unit
(Millipore, Watford, UK) with a 3-kDa cut-off limit, at 3000
g and 4 °C.
SRCD Spectroscopy and Data Analysis—Lyophilized sam-
ples of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC),
1,2-dioleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) (sodium
salt) (DOPG), 1,2-dioleoyl-sn-glycero-3-phospho-L-serine,
and/or 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine
(DOPE) were dissolved in methanol. Methanol was subse-
quently evaporated from aliquots of phospholipids using a
rotary evaporator. The lipid layer was resuspended in 100 mM
sodium phosphate buffer at pH 7.4 and bath-sonicated for 30
min. Small unilamellar vesicles were produced by passaging
the samples through an extruder with a pore size of 50 nm.
The concentration of SHERP was determined by measuring
its absorbance at 280 nm and using an experimentally deter-
mined extinction coefficient of 2689 M1 cm1, based upon
quantitative amino acid analyses (carried out at the Protein &
Nucleic Acid Chemistry Facility, University of Cambridge,
UK). SHERP and small unilamellar vesicle samples were
mixed and allowed to equilibrate for 10 min at final concen-
trations of 2.1 mg/ml SHERP, 1.4 mg/ml DOPC/DOPE (3:1
lipid ratio), or 1.6 mg/ml DOPC/DOPG (1:1 lipid ratio). SDS
solutions were prepared at room temperature by dissolving
weighed quantities of SDS powder into a 100 mM sodium
phosphate buffer, pH 7.4. Prior to data collection, samples
were degassed to remove any dissolved nitrogen or oxygen
and centrifuged at 13,000 g for 2 min to remove any insolu-
ble material and/or large vesicles. SHERP concentrations
ranged from 1.6 to 2.2 mg/ml in the lipid experiments.
SRCD spectra were acquired on Beamline CD12 at the Syn-
chrotron Radiation Source (Daresbury, UK) and/or at Beam-
line UV1 at the Institute for Synchrotron Studies (Århus,
Denmark). Samples were measured in either Suprasil quartz
circular demountable cells or calcium fluoride cells (13) with
path lengths ranging from 4.2 to 21.6 m. All samples were in
100 mM sodium phosphate buffer, pH 7.4. For samples con-
taining buffer only (no detergent or lipid) or in buffer contain-
ing 50 mM SDS, the concentration of SHERP was 5.6 mg/ml.
SHERP concentrations ranged from 1.6 to 2.2 mg/ml in the
lipid experiments. Typically, spectra were acquired at 4 °C,
over the wavelength range from 280 to 168 nm with an inter-
val of 1.0 nm and an averaging (dwell) time of 1 s (CD12) or
3 s (UV1). The low wavelength cut-off values of the data were
established from measurements of the high tension signal (a
measure of pseudoabsorption) as described previously (14).
Three repeats of each sample and base-line spectrum (which
contained all of the components present in the sample cell
except the protein) were acquired. The beamlines were cali-
brated at the beginning of each beam injection using cam-
phorsulfonic acid, as described previously (15). Small unila-
mellar vesicle stability was verified by comparisons of the
SRCD and high tension spectra obtained at the beginning and
end of spectral acquisition, with changes suggesting vesicle
instability or aggregation.
SRCD spectra were processed using CDtool software (16).
Base-line spectra were averaged and then subtracted from the
averaged sample spectra. The resulting spectra were zeroed
between 263 and 270 nm and smoothed with a Savitsky-Golay
filter (16). A mean residue weight of 112 was used in the
calculations.
The secondary structures were calculated using the
DICHROWEB server (17, 18) with the CDSSTR (19) and
CONTINLL (20) algorithms and the SELMAT (21) version of
SELCON3 (22), all with the reference data set SP175 (23). Be-
cause the helical type of secondary structure is the most accu-
rately defined by these algorithms, and because “other” is the
dominant secondary structure in this protein, the analyses
reported focus primarily on these types of secondary struc-
ture. The uncertainty () values reported are one S.D. be-
tween average calculated secondary structure values produced
from all the algorithms. The normalized root mean square
deviation value (24), which is a reflection of the difference
between the experimentally derived values for the mean resi-
due ellipticity and those calculated by the fitting algorithm, is
reported for the CONTINLL method. Values of0.10 indi-
cate that the calculated secondary structure corresponds well
to the experimental data.
Nuclear Magnetic Resonance Spectroscopy—All data were
acquired on a Bruker DRX 500 MHz (1H frequency) NR spec-
trometer equipped with a cryoprobe with the exception of the
three-dimensional 1H-13C NOESY experiment, which was
acquired with a Varian INOVA spectrometer operating at 800
MHz (1H frequency). Spectra collected at 277 K were ac-
quired using 0.5 mM SHERP in 10 mM HEPES, pH 7.4. All
spectra used for assignment and collection of structural re-
straints were acquired at 298 K using 0.5 mM SHERP in 10
mM HEPES, pH 7.4, and 50 mM SDS in a 90%/10% D2O mix-
ture. 15N,13C-labeled samples of recombinant L. major
SHERP were produced in Spectra 9-CN medium, a minimal
medium containing 0.07% 15NH4Cl and 0.2% 13C6-glucose
following the optimized purification protocol described
above. All NMR spectra for assignment data were recorded
hybrid 15N,13C-labeled samples with unlabeled detergent.
Sequence-specific backbone 1HN, 15N, 13C, 13C, and 13C
were determined using standard triple resonance methods
(for a review, see Ref. 25). H and H assignments were ob-
tained using HBHA(CBCACO)NH (25). The side chain as-
signments were completed using HCCH total correlation
spectroscopy and (H)CC(CO)NH total correlation spectros-
copy (25). Three-dimensional 1H-15N/13C NOESY-HSQC
(mixing time 100 ms at 500 and 800 MHz) experiments pro-
vided the distance restraints used in the final structure calcu-
lation. Heteronuclear 1H-15N NOE data with minimal water
saturation were acquired using the pulse sequence described
previously (26). 1H-15N residual dipolar couplings were mea-
sured in strained polyacrylamide gel according to published
methods (27).
The ARIA protocol (28) was used for completion of the
NOE assignment and structure calculation. Dihedral angle
restraints derived from TALOS (29) and 50 1H-15N residual
dipolar coupling measurements were also implemented. The
frequency window tolerance for assigning NOEs was0.04
and0.06 ppm for direct and indirect proton dimensions
and0.7 and1.2 ppm for nitrogen and carbon dimensions,
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respectively. The ARIA parameters, p, Tv, and Nv, were set to
default values. A slow cooling step was invoked using 72,000
dynamic steps of 0.003 ps (30). The 10 lowest energy struc-
tures had no NOE violations greater than 0.5 Å and no dihe-
dral angle violations greater than 5°. For the SDS titration,
increasing SDS concentrations up to 40 mM were added in
aliquots to a solution of 0.5 mM 15N-labeled SHERP in 10 mM
HEPES, pH 7.4. 2D 1H/15N HSQC spectra were recorded at
each point.
In Vitro Cross-linking with SHERP—Purified recombinant
SHERP-labeled with sulfo-SBED (SHERP-SBED in PBS)
was generated following the manufacturer’s protocol
(Pierce). The L. major strain null for the LmcDNA16 locus
encoding SHERP and HASP proteins (cDNA16::HYG/
cDNA16::PAC) (31) was maintained and subcultured as
described previously (31). Procyclic and metacyclic pro-
mastigote stages were monitored by their distinct mor-
phology and changing agglutination with peanut lectin at
days 2–3 and 6–8, respectively (31).
For cross-linking, L. major promastigotes taken after 6–8
days in culture were centrifuged at 300 rpm for 10 min,
washed three times with 0.25 M sucrose in 10 mM Tris, pH 7.4,
and then resuspended in 1 cell volume equivalent of lysis
buffer (0.2 M Tris-HCl, pH 8.0, 6 mM MgCl2, 1 mM EDTA, 1
mM DTT, 100 g/ml leupeptin, 500 g/ml Pefabloc, 5 g/ml
pepstatin, 198 g/ml 1,10-phenanthroline, 25 g/ml E64).
Cells were lysed on ice by sonication with three 10-s bursts
with 1-min intervals on ice using an XL 2020 sonicator (Lab-
caire Systems Ltd., Avon, UK) at 60% intensity. Cells were
split into two equal portions in polypropylene tubes and
placed in the dark. To one portion 7 g of SHERP-SBED per
1 109 cells were added, and both portions were then left to
incubate for 1 h on ice. Both samples were then exposed for 8
min to a 125-watt mercury lamp placed 5 cm from each open
polypropylene tube. SDS was added to a final concentration of
1% (w/v), and the cells were centrifuged at 5000 g for 5 min.
The supernatant was then removed, and aliquots were ana-
lyzed by SDS-PAGE and blotting to probe for successful bio-
tinylation using HRP-conjugated streptavidin. An Immuno-
Pure immobilized monomeric avidin column (Pierce) was
then equilibrated with PBS followed by biotin blocking and
elution buffer (2 mM D-biotin in PBS). Biotin was removed
from reversible binding sites with 12 ml of regeneration buffer
(0.1 M glycine, pH 2.8) followed by further PBS washing. The
cell supernatant samples were adjusted to a final volume of 2
ml and applied to the column. A total of six 2-ml wash steps
using PBS were carried out, followed by six 2-ml elution steps
using the biotin blocking and elution buffer. 2-ml fractions
were collected and analyzed using SDS-PAGE followed by
Coomassie or silver staining. Elution fractions from the avidin
column were then added to the washed streptavidin beads
and allowed to incubate for 1 h at room temperature. The
mixture was then centrifuged at 5000 g for 1 min, the su-
pernatant was removed, and the beads were washed four
times using PBS. 25 l of SDS-PAGE sample buffer was added
to the washed beads prior to boiling for 5 min and analysis by
SDS-PAGE. Gels were visualized using either colloidal Coo-
massie or silver staining. Fractions containing proteins iso-
lated under this protocol were digested using trypsin, and the
peptide fragments were analyzed by MALDI-TOF by Philip
Nugent in the Technology Facility at the University of York.
Surface Plasmon Resonance Studies—The affinity of SHERP
for T. thermophilus V-ATPase was studied using surface plas-
mon resonance (SPR) methods. V-ATPase was purified from
the T. thermophilus strain AH8 in which the atpA gene en-
coding the A subunit had been modified to contain a His tag
for metal affinity purification of the complex (32). The purifi-
cation protocol was carried out as described previously (32)
with the following minor modifications. First, the concentra-
tion of Triton X-100 was reduced from 1 to 0.5% in the buffer
used in the metal affinity purification step. In addition, a
Mono Q column (GE Healthcare) was used for ion exchange
chromatography, and the concentration of Triton X-100 was
reduced from 0.05 to 0.03%. All nine subunits were clearly
present based upon SDS-PAGE analysis as reported previ-
ously (32), and the sample was exchanged by spin column into
a buffer containing 10 mM Tris-HCl (pH 8.0), 100 mM NaCl,
and 0.03% n-dodecyl--D-maltopyranoside.
SPR studies were carried out using a BIAcore 2000 instru-
ment with a dextran-coated CM5 sensor chip. Two flow cells
were activated according to the manufacturer’s instructions.
To one flow cell, V-ATPase at 0.2 mg/ml in 10 mM sodium
acetate buffer, pH 5.0, was immobilized to a CM5 chip by
amine coupling. Unreacted groups on both flow cells were
capped with 100 mM ethanolamine. Both flow cells were
washed and demonstrated insignificant levels of nonspecific
binding using bovine serum albumin. Prior to injecting
SHERP, cells were washed with HBS (10 mM HEPES, 150 mM
NaCl, 0.01% (w/v) P20 detergent), and injections of 0.5 M
NaCl and 20 mM CHAPS were used to stabilize the base line.
SHERP in HBS was injected into both flow cells at six concen-
trations (0.5, 1, 2, 5, 10, and 15 M) at a flow rate of 5 l/min.
Binding curves obtained from the flow cell containing the
immobilized V-ATPase were corrected by subtraction of low
level SHERP binding to the null cell. Sensorgrams were ana-
lyzed with BIAevaluation 3.x software using a simple 1:1 bind-
ing model shown below.
A  B -|0
ka
kd
AB
REACTION 1
where KD kd/ka, and KA ka/kd.
RESULTS
Induced Folding of SHERP by Anionic Reagents—The
SHERP open reading frame from L. major was expressed and
purified to homogeneity as a recombinant protein containing
the 57 residues that comprise SHERP, followed by a 10-resi-
due non-hydrolyzable linker (33) to improve stability and a
FIGURE 1. The expressed sequence of recombinant L. major SHERP. The
translated open reading frame of SHERP sequence is shown in green, the
linker region in red, and the histidine tag in yellow.
Molecular Recognition by SHERP
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6-residue polyhistidine linker for affinity purification (Fig. 1).
Secondary structure analyses using SRCD were carried out on
purified recombinant L. major SHERP in the presence and
absence of lipids. The use of SRCD spectroscopy as opposed
to conventional CD measurements was important in these
studies for a number of reasons: 1) SRCD beamlines have a
detector geometry that reduces the apparent light scattering,
which can be problematic for membrane samples (24); 2) the
higher signal-to-noise levels enable the use of smaller
amounts of protein; 3) because lipid and detergents absorb
light, although they do not produce a CD signal, the higher
light flux of the synchrotron permits the use of higher lipid/
protein ratios; and 4) the data obtained at lower wavelengths
(170 nm compared with 190 nm) can provide more accurate
information on secondary structures (34), especially for pro-
teins that contain a large amount of disordered structure be-
cause the signature spectral characteristics for disordered
structures occur below 200 nm. Wavelengths below 200 nm
are not easily or accurately achievable for lipid-containing
samples in conventional CD instruments.
SHERP is highly soluble in aqueous solution in the absence
of lipids or detergents; however, its SRCD spectrum (Fig. 2) is
that typically found for a mostly disordered protein, with a
large negative peak at200 nm. Secondary structure analyses
on the SHERP spectrum suggest that in the absence of lipid or
detergents, the protein has little defined secondary structure
(Table 1), with only 10% of the protein being helical and
	40% being “other” (i.e. not one of the canonical helical,
sheet, or turn types of secondary structures; it is usually con-
sidered to be unordered or disordered). This experimental
observation is in contrast to a previously published protein
sequence-based secondary structure prediction, based on
computational analysis, which suggested that SHERP would
be a mainly helical structure, containing a possible turn in the
middle of its sequence (10).
Given that SHERP was previously localized near ER and
mitochondrial membranes (10), the effect of phospholipids on
the folding and structure of SHERP was examined. The addi-
tion of small unilamellar vesicles composed of either neutral
(zwitterionic) phospholipids, DOPC, or a mixture of DOPC
and DOPE produced no appreciable spectral changes or cor-
responding alterations in calculated secondary structure com-
position (Fig. 2 and Table 1) compared with SHERP alone in
aqueous solution. However, significant spectral changes (Fig.
2) were observed upon the addition of vesicles containing
equimolar amounts of DOPC and the anionic phospholipid
DOPG. Analyses of these spectra revealed a marked reduction
in the amount of “other” structure coinciding with a consider-
able increase in the amount of helical component, displaying a
maximum value of50% in the presence of DOPC/DOPG
vesicles (Table 1). In addition, SRCD spectra of SHERP col-
lected in the presence of a phosphatidylcholine/phosphatidyl-
serine mixture (data not shown) were very similar to those for
the DOPC/DOPG mixture.
The observed induced folding of recombinant L. major
SHERP was characterized in further detail using NMR spec-
troscopy. NMR spectra of SHERP alone in aqueous buffer
were consistent with SHERP adopting an unfolded or disor-
FIGURE 2. Induced folding of SHERP by anionic lipid or detergent shown
monitored by SRCD spectroscopy. SRCD spectra of SHERP are shown in
aqueous solution (black), in DOPC/DOPE (red; 1.4 mg/ml DOPC/DOPE; 3:1
lipid ratio), in DOPC/DOPG (blue; 1.6 mg/ml DOPC/DOPG; 1:1 lipid ratio),
and in 50 mM SDS (green). Anionic lipid (DOPG) or detergent (SDS) induces
SHERP to adopt a mainly helical structure.
FIGURE 3. Two-dimensional 1H-15N HSQC NMR spectrum of SHERP. Data
shown were collected at 35 °C in the absence (red) and presence (black) of
50 mM SDS. Residue assignments are shown with blue labels. Increased dis-
persion of amide resonances in the presence of SDS indicates folding of
SHERP into a distinct structure.
TABLE 1
Calculated secondary structures of L. major SHERP samples based on
SRCD data
Sample addition Helixa Otherb NRMSDc
% %
None 12 5 44 2 0.053
DOPC/DOPE 13 5 43 2 0.049
DOPC/DOPG 48 3 30 4 0.053
SDS 64 4 22 4 0.037
a Values are shown S.D. between values calculated by three different algo-
rithms (see “Experimental Procedures” for explanation).
b Unordered or disordered secondary structure.
cNormalized root mean square deviation value, a goodness of fit parameter be-
tween experimental data and calculated secondary structure (24).
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dered structure (Fig. 3). The addition of the short chain phos-
pholipid 1,2-dihexanol-sn-glycero-3-phospho-L-serine to
SHERP yielded NMR spectra with severely broadened line
widths due to the large size of the complex (data not shown).
To improve the spectral characteristics, we examined whether
SHERP could also be induced to fold in detergents that result
in smaller complexes that are more compatible with NMR
measurements. Although the neutral detergent -octyl gluco-
side detergent did not induce significant structural changes in
SHERP (data not shown), the amphipathic, anionic detergent
SDS produced a SRCD spectrum characteristic of a mostly
helical structure similar to that found for the protein in the
anionic lipids (Fig. 2). Analyses of the spectra obtained for
SHERP in the presence of SDS or the DOPC/DOPG mixture
both indicate a helical content of50–60% (Table 1). Taken
together, these results suggest that an anionic environment is
key to driving the structural transition of SHERP from a pre-
dominantly unordered structure to one possessing significant
-helical content. Comparison of the measured secondary
structures of the construct in the presence of these partner
molecules with that predicted based on sequence methods
(10) produces similar results; the C-terminal 16-residue addi-
tion, including the His tag, is not predicted to form an or-
dered structure, but 39 of the 73 total residues are, which cor-
responds to a structure that would be 53% helical (35).
Interestingly, sequence-based disorder predictions (36) only
identify the termini as disordered and so do not suggest that it
would be disordered in the absence of a binding partner.
The Solution Structure of SHERP—The high resolution so-
lution structure of SHERP in the presence of SDS was solved
using heteronuclear multidimensional NMR spectroscopy.
Initially, 15N-labeled SHERP was analyzed by two-dimen-
sional NMR methods. In the absence of SDS, the 1H-15N
HSQC spectrum of SHERP showed a narrow 1H chemical
shift dispersion clustered mainly between 8.0 and 8.6 ppm
(Fig. 3), suggesting that SHERP is unstructured and highly
dynamic in solution. Spectra were also collected at 4 °C in an
attempt to maximize the likelihood of stabilizing the structure
(supplemental Figs. S1 and S2). The observation of the three
Gly cross-peaks at low temperatures compared with higher
temperatures is probably due to the reduced amide exchange
with water. It is unlikely that the spectral dispersion of these
three Gly residues is due to residual structure because the rest
of the amides do not show evidence for this, and the hetero-
nuclear NOE (Fig. 3) confirms the highly dynamic nature of
an unfolded polypeptide. These observations are also consis-
tent with the SRCD spectrum of SHERP at 4 °C (Fig. 2), col-
lected in the absence of SDS or lipids, that shows that SHERP
is a mostly disordered protein. Upon titration with SDS, the
spectrum displays a wide dispersion of the amide resonances,
indicative of a fully folded protein with regular secondary
structure (Fig. 3); the saturation point for the titration of SDS
with L. major SHERP was obtained at a ratio of 80:1
(SDS/SHERP).
The backbone assignment of the 15N/13C-labeled L. major
SHERP was carried out using standard triple resonance meth-
odology (25). Of the 73 residues that comprise this recombi-
nant form of SHERP, peaks corresponding to 66 residues were
assigned, which include 56 of 57 residues encoded by the
SHERP open reading frame and the 10 residues present in the
non-hydrolyzable linker. No assignment was made of the N-
terminal methionine or the 6 residues of the C-terminal poly-
histidine tag, although the latter did show some increase in
order most likely arising from electrostatic interactions with
the SDS micelle. Analysis of chemical shift values for SHERP
using the TALOS program (29) revealed that 46 of the 66 resi-
dues were predicted to adopt a helical conformation.
Using a combination of manual and automated NMR as-
signment methods for analysis of NOESY spectra (28), a fam-
ily of high resolution structures for L. major SHERP in the
presence of SDS micelles was calculated (Fig. 4a), with excel-
lent agreement with experimental data and structural quality
(Table 2). All areas of secondary structure are very well de-
fined; the average pairwise root mean square deviation for the
water-refined final structures is 0.19 0.05 Å for the back-
bone atoms and 0.65 0.17 Å for the heavy atoms of residues
present in secondary structure. Steady-state heteronuclear
NOE data show that L. major SHERP in the presence of SDS
possesses flexible N and C termini (Fig. 5).
As shown in Fig. 4b, the structure for monomeric L. major
SHERP in the presence of SDS adopts a helix-turn-helix mo-
tif. The flexible N-terminal region is followed by the first he-
lix, which stretches from Gln3 to Leu27, and then a hairpin
turn followed by a second helix from residue Gly32 to Leu53
and finally the flexible C-terminal region. These regions of
secondary structure correlate well with the backbone dynam-
FIGURE 4. The solution structure of SHERP incorporated into SDSmi-
celles. a, the final family of 10 high resolution structures for L. major SHERP
determined in the presence of SDS micelles. b and c, ribbon diagram and
electrostatic surface representation of SHERP in two 90° orientations. The N
terminus of SHERP (N) is shown in a and b. Only the coordinates for residues
corresponding to the L. major encoded SHERP sequence are shown. Images
were produced using PyMOL (DeLano Scientific LLC).
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ics calculated from the heteronuclear NOE values, where high
heteronuclear NOE values (indicating increased rigidity; Fig.
5) correspond to regions of low flexibility (small root mean
square deviation values). Visualization of the calculated sur-
face electrostatic potential of this structure for SHERP (Fig.
4c) shows it to be amphipathic with positively charged resi-
dues, such as lysine and arginine, being present on opposite
faces to negatively charged aspartate and glutamate residues.
SHERP Can Form a Complex with Vacuolar ATPase—Ear-
lier localization studies identified SHERP as a peripheral
membrane protein (10), and the in vitro studies described
above indicate that SHERP can be induced to fold in the pres-
ence of anionic phospholipids or SDS. Although these find-
ings raise the possibility that SHERP may form specific inter-
actions with anionic phospholipids in vivo, the protein may
also form protein-protein interactions with other binding
partners in a membrane environment, as suggested previously
(10). To explore this hypothesis further, L. major SHERP was
labeled with the chemical cross-linking reagent sulfo-SBED to
yield SHERP-SBED. This form of the protein was then incu-
bated with a lysed culture of metacyclic promastigotes of a
genetically modified strain of L. major (cDNA16::HYG/
cDNA16::PAC) lacking both alleles of the LmcDNA16 locus
that codes for the SHERP genes (31). SHERP-SBED-cross-
linked complexes, which contain a biotin affinity label, were
isolated by streptavidin affinity chromatography. Fractions
from column elutions and washes were collected and analyzed
by SDS-PAGE (supplemental Fig. S3). Eight samples (five
from the wash and three from the elution) were excised from
these gels and then submitted for MALDI-TOF mass spec-
trometry analysis.
Five proteins (supplemental Table S1) were identified with
statistically significant levels of confidence: one protein from
the column elution step, subunit B of V-ATPase, and four
proteins from the column wash (peroxidoxin, paraflagellar
rod protein, the heat shock protein Hsp70, and the SA sub-
unit of the 40 S ribosome). The four proteins in the wash frac-
tions probably represent false positive results, derived from
proteins present at high abundance in the parasite lysates (as
shown in proteomic analyses (e.g. see Ref. 37)) that have non-
specifically bound to the affinity column. Such proteins would
be expected to be present in this fraction, and their identifica-
tion represents a robust control. In comparison, subunit B
from the vacuolar or V-ATPase was isolated from the column
elution step, suggesting that it was indeed captured as a bio-
tin-labeled cross-linked complex with SHERP. V-ATPase is a
membrane protein complex known to be involved in the acid-
ification of intracellular compartments in eukaryotes; subunit
B is one of the two large components that form the extracellu-
lar catalytic rotor (reviewed in Refs. 38–40). Given that vacu-
olar acidification is known to occur during parasite differenti-
ation (discussed below), V-ATPase was thus considered to be
a potential genuine binding partner for SHERP.
To further study the interaction of L. major SHERP with
V-ATPase, we have used surface plasmon resonance to obtain
the binding affinity of SHERP for the V-ATPase homologue
from T. thermophilus, a well characterized membrane protein
complex with subunits that can be purified for in vitro studies
(32). Amino acid sequence alignment of subunit B from
T. thermophilus and L. major demonstrates sufficient levels of
identity and similarity (56 and 72%, respectively (supplemen-
tal Fig. S4)) to support the use of T. thermophilus V-ATPase
as a good model system to assess complex formation with
SHERP. Sensorgrams (supplemental Fig. S5) of L. major
SHERP binding to T. thermophilus V-ATPase complex immo-
bilized to a CM5 dextran chip show rapid association and dis-
sociation phases. A concentration-independent elevated base
line is also observed following the dissociation phase that may
indicate a small but constant amount of irreversible binding
of SHERP to the chip surface containing immobilized V-AT-
Pase. However, the observation of a rapid dissociation phase
suggests that SHERP mainly interacts with V-ATPase in a
specific and reversible manner. Non-linear regression using
the global fitting Bioevaluation 3.x software yielded a KD of
2.0 0.1 M, indicative of the formation of a functionally sta-
ble complex between SHERP and the T. thermophilus
V-ATPase.
TABLE 2
NMR and refinement statistics for L. major SHERP in SDS
Parameter Value
No. of experimental restraints
Total NOE-derived 883
Ambiguous 415
Unambiguous 468
TALOS (f/y) 114
Root mean square deviation from experimental
restraints
Distance (Å) 0.04 0.003
Dihedral angle (degrees) 1.0 0..02
Root mean square deviation from idealized
covalent geometry
Bonds (Å) 0.0035 0.0001
Angles (degrees) 0.71 0.008
Energies (kcal mol1)
ENOE 84.8 22.5
Ebond 12.8 0.3
Eangle 138 3.5
Evdw 583 4.5
Coordinate root mean square deviation (Å)
Backbone atoms in secondary structure 0.19 0.03
Heavy atoms in secondary structure 0.65 0.17
Ramachandran plot
Residues in favored regions (%) 77
Residues in allowed regions (%) 20
Residues in outlier regions (%) 3a
a The outliers include residue Asp2, which is so near to the N terminus that it
shows some evidence of flexibility, and Asp29, which lies at the apex of the heli-
cal hairpin.
FIGURE 5. Steady-state heteronuclear 15N-1H NOE values for SHERP in a
1:100molar ratio with SDS. Rigid secondary structural elements are char-
acterized by a high heteronuclear NOE, whereas lower values indicate sig-
nificant flexibility on the pico- to nanosecond time scale. Black circles show
the experimentally determined values, and the red error bars represent one
S.D. value. A secondary structure prediction using chemical shift values is
shown above for comparison.
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DISCUSSION
Identification of a Molecular Recognition Template for
SHERP Folding—In this study, both biophysical and biochem-
ical approaches have been used to gain more information
about SHERP and its molecular interactions, in order to ad-
vance our understanding of the role of this unusual small
molecule. We produced a new recombinant form of SHERP,
8 kDa, containing a 6-residue C-terminal polyhistidine tag
and small non-hydrolyzable linker, to enable rapid purifica-
tion and to improve its stability against proteolytic degrada-
tion. SHERP is a highly soluble protein, which was shown
here to exist in a predominantly disordered state in aqueous
solution using SRCD (Fig. 2 and Table 1) and NMR (Fig. 3 and
supplemental Figs. S1 and S2). Based upon its hydrophilicity
and apparent lack of membrane spanning or anchoring mo-
tifs, together with in vivo cross-linking data, it has been previ-
ously suggested that SHERP is a peripheral membrane protein
that localizes on the cytosolic side of membranes, perhaps in
association with another integral or peripheral membrane
protein (10).
To explore this hypothesis further, we initiated studies to
assess whether SHERP could interact with phospholipids. A
key but unexpected finding was that this protein can be in-
duced to fold by vesicles containing anionic phospholipids.
SRCD spectra (Fig. 2 and Table 1) of SHERP in the presence
of vesicles containing DOPG or 1,2-dioleoyl-sn-glycero-3-
phospho-L-serine clearly show that the helical content of the
protein increases significantly. This effect could also be mim-
icked using the anionic detergent SDS and was observed using
both SRCD (Fig. 2 and Table 1) and heteronuclear NMR (Fig.
3) methods. Furthermore, the observations that SHERP does
not fold in the presence of neutral phospholipids or neutral
detergents suggest that the molecular recognition template
that triggers SHERP to fold in vivo is dominated by a posi-
tively charged electrostatic surface. This hypothesis is further
supported by the amphipathic nature of the globular fold of
SHERP, determined in the presence of SDS using multidi-
mensional heteronuclear NMR methods. As shown in Fig. 4b,
SHERP adopts a well defined amphipathic helix-turn-helix
fold from residue 3 to 53, consistent with earlier bioinfor-
matic predictions (10) and with the helical propensity ob-
served in the SRCD spectra. A clear distribution of electro-
statically positive and negative regions on opposite faces of
the folded structure of SHERP is also evident, as seen in
Fig. 4c.
The ability of anionic phospholipids to induce protein fold-
ing is a phenomenon that has been well characterized in pro-
teins such as -synuclein (41, 42) and human plasma apolipo-
protein A-I (43). These proteins adopt amphipathic helical
folds with a membrane recognition motif characterized by
11-residue repeating units (44, 45). Molecular “stripes” of
neutral or negative or positively charged residues are visible
along the distinct faces of the helices. The charge distribution
observed in these -helical structures was first used to pro-
pose a mode of binding to the lipid surface by apolipoproteins
(44) where positively charged side chains interact with the
negatively charged phospholipid headgroup (46). In this
model, the hydrophobic interaction of helices penetrates to a
depth of3 Å into the lipid surface, an effect often described
as “snorkeling,” with larger assemblies forming a “carpet” of
extended helices, an observation initially supported by NMR
studies of apolipoprotein C-II in dodecyl phosphocholine
(47). More recently, the three-dimensional NMR structure of
the complex apolipoprotein C-III with SDS clearly shows that
this protein wraps itself around an SDS micelle as a “necklace”
of extended helices (48). The “snorkeling” interaction with
phospholipids was also proposed for -synuclein (49) and
supported by EPR spin labeling studies (50, 51). However,
there is considerable debate about the conformation of mem-
brane-bound -synuclein. Current data indicate that a bent
helical or helix-turn-helix-type fold is present when -sy-
nuclein is in complex with detergent micelles (52, 53), al-
though at very high concentrations of SDS (where SDS is
more rodlike in structure), alternative binding modes have
been observed, including an extended elongated helical fold
(54). Several different binding modes have also been proposed
to occur in biological membranes, possibly due to differences
in composition and curvature. These include the bent (helix-
turn-helix) helix fold (55) and an elongated extended helix
(51, 53), both of which would be embedded in a membrane/
vesicular surface in vivo. In addition, a recent NMR study sug-
gests that -synuclein may assemble into -helical bundles
that could enable the protein to penetrate deeper into a mem-
branous bilayer (56).
SHERP, in comparison, lacks the strong repetitive character
seen in the 11-residue repeats of apolipoproteins (57, 58) and
-synuclein (45). However, as shown in Fig. 4c, the electro-
static distribution of charge surrounding its helices clearly
shows that SHERP possesses the characteristic amphipathic
properties typical of other helical proteins that bind anionic
phospholipids (44). Thus, in a similar manner to apolipopro-
teins and -synuclein, the amphipathic helical fold of SHERP
could allow it to be surface-localized on membrane surfaces
when sufficient concentrations of anionic phospholipids are
present. It is also worth noting that the hairpin turn observed
in SHERP differs from the other helix-forming sequences in
this molecule in that it contains a glycine residue (Gly31) that
can act together with nearby residues to favor hairpin forma-
tion. In the -synuclein complex with SDS (59), a similar turn
is observed in its three-dimensional structure (52, 53).
The NMR-determined structure of SHERP in the presence
of SDS does not discount the possibility that this protein
could adopt alternative conformations and/or binding modes
in vivo. For example, it has been argued that SDS micelles are
limited in their capability to mimic a membrane bilayer due to
their small size and high curvature (50, 51). The SRCD data
reported here shows a higher helical content (16%) for SHERP
in the presence of SDS compared with vesicles containing
anionic phospholipids (Table 1 and Fig. 2), suggesting the
presence of some conformational differences. Indeed, a simi-
lar increase in helical content has been reported previously for
-synuclein under analogous conditions using CD (59), and
EPR and FRET studies indicate that -synuclein adopts an
extended helical fold on a membrane surface (51, 53). It is also
important to note that the interhelical interactions of SHERP
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observed in the NMR data in SDS reported here could arise
from interactions between independent monomeric units.
Such interactions could permit SHERP to “carpet” or “cluster”
on membrane surfaces (49, 60) or even form membrane-pen-
etrating -helical bundles (56) as described previously for
-synuclein. Given the plethora of biophysical approaches to
study membrane-protein interactions, future studies can ex-
amine whether the fold and/or oligomeric state of SHERP
differ significantly in the presence of membrane bilayers from
what is reported here.
Potential Functional Roles of SHERP—Metacyclogenesis in
Leishmania represents the end point of parasite development
in the sand fly vector, when parasites cease cell division and
are preadapted for inoculation into and survival within the
mammalian host (4). Generation of metacyclic parasites can
be induced by low pH and nutrient depletion in vitro, whereas
reduced tetrahydrobiopterin levels may also act as a signal for
parasite differentiation in vivo (61, 62). These differentiated
parasites display distinctive morphological and biochemical
features; they have a small cell body and relatively long flagel-
lum and are highly motile and resistant to human comple-
ment, thereby facilitating parasite survival in the host follow-
ing transmission. Complement resistance is associated with
presence of an extensive glycocalyx composed chiefly of the
complex lipid-anchored glycoconjugate, lipophosphoglycan.
Modification of lipophosphoglycan during metacyclogenesis
facilitates parasite detachment from the mid-gut in the sand
fly and is essential for vector transmission (reviewed in Ref. 8).
The identity and function of other parasite factors required in
later stages of development and their role in metacyclic trans-
mission are poorly understood.
SHERP, together with HASPB, were originally identified as
two of the few differentially regulated genes in L. major, ex-
pressing high RNA and protein levels predominantly in meta-
cyclic parasites (10, 63–65), both in culture and, more re-
cently, in metacyclics dissected from sand flies (66). Both
proteins are encoded within the LmcDNA16 gene locus on
chromosome 23 (63). Homozygous null mutants deleted for
the whole diploid locus, generated by targeted gene deletion,
are still infective in vitro (in cultured macrophages) and in
vivo (in a susceptible BALB/c mouse model) (31). These in
vivo experiments involved direct needle inoculation of cul-
tured parasites, however, rather than their introduction by
sand fly bite, experimental conditions that more closely
mimic in vivo transmission. Recent data have shown that the
null mutants described above, that are also more sensitive to
complement lysis than wild type parasites, are compromised
in their development in the sand fly vector (66). Genetic com-
plementation of the null phenotype confirms that the
LmcDNA16 locus is essential for metacyclogenesis in vivo.
Previous work using indirect immunofluorescent imaging,
immunogold electron microscopy, and cell fractionation
demonstrated that SHERP associates with the ER and outer
mitochondrial membranes as a peripheral membrane protein
(10). Additional experiments to investigate potential SHERP-
cytoskeletal interactions or its influence on organellar mor-
phology showed no significant effects. Overall, these data
have given limited insight into the functional role of SHERP
in metacyclic Leishmania.
The amphipathic nature of SHERP, its localization at intra-
cellular membranes (10), and its ability to interact with ani-
onic phospholipids suggest that one function of SHERP may
be to bind and possibly recruit anionic lipids during metacy-
clogenesis. Characterization of total membrane composition
in Leishmania promastigotes (but not specifically metacyclic
parasites) has identified the neutral phospholipids (phosphati-
dylcholine and phosphatidylethanolamine) as principal com-
ponents, with negatively charged phospholipids (phospha-
tidylinositol, phosphatidylglycine, and phosphatidylserine)
also present but in considerably smaller quantities (67–69).
The structural similarities between SHERP and apolipopro-
teins or -synuclein suggest that SHERP may not only embed
itself in a membrane surface but possibly penetrate into the
bilayer. These modes of membrane interaction suggest that
SHERP might be required for cellular reorganization or sig-
naling processes occurring during parasite differentiation.
The identification of V-ATPase as another potential bind-
ing partner of SHERP raises the possibility that this protein
may have some role in modulating V-ATPase-dependent cel-
lular processes in vivo. These molecular complexes are mem-
brane-localized ATP-driven proton pumps that are primarily
responsible for acidification in a variety of intracellular endo-
somal/lysosomal-type compartments and secretory vesicles as
well as for proton transport across the plasma membrane in
eukaryotes. In general, eukaryotic V-ATPases contain 14 sub-
units of varying stoichiometries that assemble as V1, a periph-
eral membrane complex containing the catalytic ATPase ac-
tivity and V0, an integral membrane motor complex (39, 70).
This architecture is also shared by the intact T. thermophilus
V-ATPase formed from nine subunits, which principally dif-
fers from eukaryotic V-ATPases in its V0 rather than the V1
subcomplex assembly (71). A key feature of V-ATPase is that
dynamic and reversible disassembly of the V1 from the V0
complex regulates its activity, and this has been shown to be
important for a wide range of cellular processes related to
acidification (38, 72, 73). Data presented here indicate that
SHERP may have the potential to form a functionally stable
complex with the L. major V-ATPase in vivo, presumably
through interactions with the V1 subcomplex. If this occurs,
SHERP could either prevent dissociation of the V-ATPase
complex from a membrane, perhaps enhancing organelle
acidification, or inhibit the catalytic activity V1 subcomplex
through interactions with subunit B or other subunits in a
manner analogous to that observed for the eukaryote-specific
subunit H regulatory protein (74).
Optimum expression of SHERP occurs in metacyclic para-
sites that have a short extracellular life span within the sand
fly prior to transmission and phagocytosis by host macro-
phages. Within these phagocytic cells, metacyclic Leishmania
are maintained within the phagosome, an acidic lysosomal/
endocytic compartment, prior to differentiation into amotile
amastigotes (75). In addition, autophagy has been identified as
a key process for Leishmania differentiation and parasite viru-
lence (76–78). This catabolic process, common in eukaryotic
cells, appears to be essential for the extensive cellular remod-
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eling and size changes associated with progression through
the stages of the parasite life cycle. In particular, metacyclo-
genesis has been shown to be dependent on late endosome
function and autophagy, with the multivesicular body-like
network found in multiplicative promastigotes maturing into
a lysosomal-like structure of high lytic capacity and low pH in
metacyclic cells (76). Given the localization of SHERP to mi-
tochondrial and ER membranes (both of which can be pro-
cessed by autophagic digestion) and its potential interaction
with the V-ATPase in vitro, perhaps this small protein plays a
regulatory role in the vacuolar acidification associated with
parasite autophagy in the vector.
In summary, we have developed a strategy using a range of
biophysical and biochemical studies to elucidate structural
properties and identify molecular interactions of the unusual
Leishmania protein, SHERP. These studies have established
that the structure of SHERP is highly disordered in solution,
whereas in the presence of anionic phospholipids or deter-
gent, it adopts a highly helical fold with properties that could
enable it to embed or even penetrate into a membrane bilayer.
Our data suggest that the molecular recognition template that
induces this structural transformation in SHERP is an anionic
surface and that anionic phospholipids and/or V-ATPase may
be among the potential binding partners of SHERP in vivo.
Taken together, these observations suggest a number of po-
tential roles for SHERP that can now be assessed in the con-
text of the whole organism.
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